Design of the nanointerface for detection, recovery, and regeneration of abnormal proteins
Design of the nanointerface for detection, recovery, and regeneration of abnormal proteins
批准号:
14380412
负责人:
FUJIMOTO Keiji
金额:
$7.1万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Polymeric nanoparicles have been paid to attention as a drug carrier. It is required that carriers are inert and non-toxic and are not accumulated or are degradable in the body. Therefore we selected poly-L-lysine (PLL) that is degradable polypeptide for a backbone of a nanoparticle. Because PLL exhibits structural changes among random, helix, and β-sheet by pH and temperature, we expect the stimuli-sensitive release of drugs from nanoparticles.PLL was allowed to react with poly (ethylene glycol) (PEG) to improve the dispersion-stability and to prolong the lifetime in blood (mPEG-PLL polymer). Then, mPEG-PLL polymer was coupled with phosphatidic acid (PA) that acts as a hydrophobic site (mPEG-PLL-PA nanoparticle). The obtained polymers spontaneously aggregated into a nanoparticulate shape by the hydrophobic association among PA moieties. Whilst mPEG-PLL polymers were assembled to nanoparticles upon the formation of β-sheet structure in high pHs and high temperatures (mPEG-PLL nanoparticle). Both nanoparticles were 10-80nm in size and possessed the positive change. FITC-labeled nanoparticles were internalized into A431 cells. Adriamycin (ADR) that is an anticancer drug was incorporated into mPEG-PLL-PA nanoparticle more than mPEG-PLL nanoparticle because of PA's great hydrophobicity. However, drug release showed an opposite tendency. In pH4, release rate of ADR from mPEG-PLL nanoparticles was faster than that from mPEG-PLL-PA nanoparticles. Thereby survival rate of A431 cells decreased when they were treated with ADR-loaded mPEG-PLL nanoparticles.We applied β-sheet association of the mPEG-PLL polymer to inhibition of protein aggregation. PLL tends to aggregate through β-sheet association by raising pH and temperature. This aggregation could be inhibited by adding the mPEG-PLL polymer. This suggests that the mPEG-PLL polymer is capable of inhibiting aggregation of abnormal proteins that cause conformational diseases.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Nakahama, K: "Thermosensitive 2-dimensional arrays of particles"Langmuir. Vol.18. 10095-10099 (2002)
Nakahama, K:“热敏二维粒子阵列”Langmuir。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
異方性粒子の作製とそのはたらき
各向异性颗粒的制备及其功能
DOI:
--
发表时间:
2005
期刊:
繊維と工業 61・1
影响因子:
--
作者:
[藤本啓二]
通讯作者:
藤本啓二
藤本啓二: "ナノ粒子"血液・免疫・腫瘍. Vol.8. 119-123 (2003)
Keiji Fujimoto:“纳米颗粒”血液、免疫学和肿瘤,第 8 卷(2003 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
リボソームを鋳型とする中空ナノ粒子の作製方法
以核糖体为模板制备中空纳米粒子的方法
DOI:
--
发表时间:
2004
期刊:
影响因子:
--
作者:
[]
通讯作者:
藤本啓二: "微粒子の集積化"高分子. Vol.52, No.9. 701-705 (2003)
Keiji Fujimoto:“细颗粒的整合”,第 52 卷,第 701-705 期(2003 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
Soluble urokinase receptor; a new diagnostic and therapeutic biomarker for nephrotic syndrome
-
批准号:18K15988
-
项目类别:Grant-in-Aid for Early-Career Scientists
-
资助金额:$2.58万
-
财政年份:2018
-
负责人:FUJIMOTO Keiji
-
依托单位:
Development of next generation nano-biomaterials by cell surface engineering
-
批准号:19300176
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.06万
-
财政年份:2007
-
负责人:FUJIMOTO Keiji
-
依托单位:
海外基金